Index
Page 2
Two letter's from the FDA to Lafayette pharmaceutical in which the
FDA criticizes Lafayette for not providing regular
reports on Pantopaque, and also the FDA ordered Lafayette to change
the labeling of Pantopaque and to include warnings of severe
reactions it causes, namely Adhesive Arachnoiditis.
